SCHEMBL738622

SCHEMBL738622

CCCCCCCCCCOc1cscc1OCCCCCCCCCC

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR5A1 Q13285 1/20 0.44
MEN1 O00255 1/20 0.43
NR1I2 O75469 1/20 0.43
LMNA P02545 1/20 0.43
CHRM2 P08172 1/20 0.43
CYP3A4 P08684 1/20 0.43
ADRA2A P08913 1/20 0.43
MAPT P10636 1/20 0.43
OPRK1 P41145 1/20 0.43
HTR2B P41595 1/20 0.43
SLC6A3 Q01959 1/20 0.43
KMT2A Q03164 1/20 0.43
HDAC6 Q9UBN7 1/20 0.43
TSHR P16473 2/20 0.43
MCHR1 Q99705 1/20 0.40
TLR8 Q9NR97 1/20 0.40
CYP1A2 P05177 1/20 0.39
CYP2C9 P11712 1/20 0.39
CYP2C19 P33261 1/20 0.39
CHUK O15111 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2745110 1.00 NR5A1 (0.44) NR5A1MEN1NR1I2LMNACHRM2
SCHEMBL9508243 1.00 NR5A1 (0.44) NR5A1MEN1NR1I2LMNACHRM2
SCHEMBL2745120 1.00 NR5A1 (0.44) NR5A1MEN1NR1I2LMNACHRM2
SCHEMBL2745290 1.00 NR5A1 (0.44) NR5A1MEN1NR1I2LMNACHRM2
SCHEMBL739572 1.00 NR5A1 (0.44) NR5A1MEN1NR1I2LMNACHRM2
SCHEMBL5057971 1.00 NR5A1 (0.44) NR5A1MEN1NR1I2LMNACHRM2
SCHEMBL741426 1.00 NR5A1 (0.44) NR5A1MEN1NR1I2LMNACHRM2
SCHEMBL739382 1.00 NR5A1 (0.44) NR5A1MEN1NR1I2LMNACHRM2
SCHEMBL2744960 1.00 NR5A1 (0.44) NR5A1MEN1NR1I2LMNACHRM2
SCHEMBL741013 1.00 NR5A1 (0.44) NR5A1MEN1NR1I2LMNACHRM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 410 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11915838-B2 Self-healing and stretchable polymeric compositions THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ALABAMA (US) 2024-02-27 US claimed
US-20210375501-A1 SELF-HEALING AND STRETCHABLE POLYMERIC COMPOSITIONS THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ALABAMA 2021-12-02 US claimed
US-7321012-B2 Method of crosslinking intrinsically conductive polymers or intrinsically conductive polymer precursors and the articles obtained therefrom THE UNIVERSITY OF CONNECTICUT (US) 2008-01-22 US claimed
US-20040242792-A1 Method of crosslinking intrinsically conductive polymers or intrinsically conductive polymer precursors and the articles obtained therefrom CONNECTICUT, THE UNIVERSITY OF 2004-12-02 US claimed
CN-122071617-A Aqueous coating agent and laminate 尤尼吉可株式会社 2026-05-22 CN disclosed
EP-4737520-A1 CONDUCTIVE COMPOSITE DISPERSION LIQUID AND METHOD FOR PRODUCING SAME, CAPACITOR AND METHOD FOR PRODUCING SAME, AND CONDUCTIVE MULTILAYER BODY AND METHOD FOR PRODUCING SAME Shin-Etsu Polymer Co., Ltd. (JP) 2026-05-06 EP disclosed
US-12527506-B2 Conductive composition, biomedical electrode, and biomedical sensor NITTO DENKO CORPORATION (JP) 2026-01-20 US disclosed
EP-4640769-A1 CONDUCTIVE POLYMER-CONTAINING DISPERSION, SOLID ELECTROLYTE CAPACITOR, AND PRODUCTION METHOD FOR SAME Resonac Corporation (JP) 2025-10-29 EP disclosed
US-12444322-B2 Simulated blood vessel and ulcer model using same DENKA COMPANY LIMITED (JP) 2025-10-14 US disclosed
EP-4338921-B1 SIMULATED BLOOD VESSEL AND ULCER MODEL USING SAME DENKA COMPANY LTD (JP) 2025-10-08 EP disclosed
US-20250304801-A1 CONDUCTIVE COMPOSITION AND PRODUCTION METHOD THEREFOR, AND WATER-SOLUBLE POLYMER AND PRODUCTION METHOD THEREFOR MITSUBISHI CHEMICAL CORPORATION (JP) 2025-10-02 US disclosed
US-12415930-B2 Conductive polymer composition, substrate, and method for producing substrate SHIN-ETSU CHEMICAL CO., LTD. (JP) 2025-09-16 US disclosed
US-20060076541-A1 Conductive composition and production method thereof, antistatic coating material, antistatic coating, antistatic film, optical filter, and optical information recording medium, and capacitors and production method thereof SHIN-ETSU POLYMER CO., LTD. 2006-04-13 US disclosed
US-20060062958-A1 Conductive composition and production method thereof, antistatic coating material, antistatic coating, antistatic film, optical filter, and optical information recording medium, and capacitors and production method thereof SHIN-ETSU POLYMER CO., LTD (JP) 2006-03-23 US disclosed
EP-1634922-A1 CONDUCTIVE COMPOSITION, CONDUCTIVE COATING MATERIAL, CONDUCTIVE RESIN, CAPACITOR, PHOTO-ELECTRIC CONVERTING ELEMENT, AND PROCESS FOR PRODUCING THE SAME SHIN-ETSU POLYMER CO., LTD. (JP) 2006-03-15 EP disclosed
US-20040242792-A1 Method of crosslinking intrinsically conductive polymers or intrinsically conductive polymer precursors and the articles obtained therefrom CONNECTICUT, THE UNIVERSITY OF 2004-12-02 US disclosed
EP-0885251-B1 SUBSTITUTED POLYTHIOPHENES, PROCESSES FOR THEIR PREPARATION AND THEIR USE BASF AG (DE) 2001-08-16 EP disclosed
US-6242561-B1 USED AS SEMICONDUCTORS; ELECTROCHROMIC AND ANTISTATIC PROPERTIES BASF AKTIENGESELLSCHAFT (DE) 2001-06-05 US disclosed
EP-0885251-A1 SUBSTITUTED POLYTHIOPHENES, PROCESSES FOR THEIR PREPARATION AND THEIR USE BASF AKTIENGESELLSCHAFT (DE) 1998-12-23 EP disclosed
WO-1997032914-A1 SUBSTITUTED POLYTHIOPHENES, PROCESSES FOR THEIR PREPARATION AND THEIR USE BASF AKTIENGESELLSCHAFT (DE) 1997-09-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12527506-B2 Conductive composition, biomedical electrode, and biomedical sensor TNNT2, PRNP, TNNI3 NR5A1 3362/4885MEN1 4238/4885NR1I2 664/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.